Tijdschrift voor psychiatrie最新文献_第6页

[The nurse practitioner as responsible clinician: opportunities and challenges]. 【护士作为负责任临床医生：机遇与挑战】。

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

M J van Til, J M C van Dam, D G Hollands, M B de Koning

{"title":"[The nurse practitioner as responsible clinician: opportunities and challenges].","authors":"M J van Til, J M C van Dam, D G Hollands, M B de Koning","doi":"","DOIUrl":"","url":null,"abstract":"Background: The Compulsory Mental Health Care Act in the Netherlands (CMHCA) came into effect in 2020. Mental health nurse practitioners have since been allowed to be ‘responsible clinician’ However, there seems to be diversity in the implementation of the role in practice.Aim: To investigate the state of affairs regarding the role of the mental health nurse practitioners as ‘responsible clinician’ within the CMHCA and reflecting on this topic.Method: Legislative texts, guidelines and professional associations have been consulted. The quality and professional statutes of eighteen large mental health institutions in the Netherlands were also studied, using the search terms ‘responsible clinician’, ‘Compulsory Mental Health Care Act’, ‘nurse practitioner’, ‘CMHCA’.Results: The CMHCA leaves room for precise interpretation of the role of responsible clinician. In more than half of the quality and professional statutes examined (N=10), the role of responsible clinician is not specified. The other statutes (N = 8) include various frameworks for the role of a mental health nurse practitioner as responsible clinician.Conclusion: The role of the nurse practitioner as responsible clinician is not clearly described in the statutes and guidelines reviewed. The CMHCA leaves room for how to fulfill this. We recommend a broad field consultation to arrive at clearer advice about which discipline is responsible clinician in which situation.","PeriodicalId":23100,"journal":{"name":"Tijdschrift voor psychiatrie","volume":"67 1","pages":"28-32"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143011953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[On the future relevance of mental health care for population mental health]. [论心理保健对人口心理健康的未来意义]。

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

P Bracke

{"title":"[On the future relevance of mental health care for population mental health].","authors":"P Bracke","doi":"","DOIUrl":"","url":null,"abstract":"Background: Opinions differ on the societal importance of mental health care (GGZ) and the direction it should take. Is there a need for prevention targeting high-risk health groups, should more attention be paid to precision psychiatry, or is the focus better placed on promoting a mentally healthy lifestyle or accessible care in disadvantaged neighborhoods?Aim: To outline the social importance of mental health care from three perspectives: the biomedical-clinical approach, the moral-philosophical, social-critical perspective and an approach that emphasizes social inequality and disadvantage. Further I reflect on the possible importance of some innovations in mental health care for future general mental health.Method: Literature review and consideration.Results: Questions about the social importance of mental health care and the future direction of mental health care are typically viewed from a biomedical and clinical perspective, with the assumption that what benefits patients is also the most direct path to improved public mental health. However, other narratives also dominate the discussion, such as socio-critical approaches or perspectives emphasizing social inequality and marginalization.Conclusion: Anyone who examines these approaches from a public health perspective must conclude that many innovations in mental health care are largely irrelevant to public mental health, despite their impact on the relationship between society and mental health care.","PeriodicalId":23100,"journal":{"name":"Tijdschrift voor psychiatrie","volume":"67 2","pages":"124-128"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143574060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[The psychiatry residency program: looking 10 years ahead]. [精神病学住院医师项目：展望未来10年]。

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

D W Strijbos, A W Braam, P K H Deschamps, G Glas, U Klumpers

引用次数: 0

[First episode psychosis associated with increased volume of an arachnoid cyst in the posterior fossa]. [首发精神病与后窝蛛网膜囊肿体积增大有关]。

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

L Van Buggenhout, F-L De Winter

引用次数: 0

[Psychedelica bij de behandeling van psychiatrische aandoeningen anno 2025]. [2025年精神疾病治疗中的致幻剂]。

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

R E Blom, T Bostoen, O J N Bloemen, A E Schröder, J J Breeksema, M van Elk, W van den Brink, M Somers

引用次数: 0

[Van onderbuik naar onderbouwd: psychometrie naar de klinische kern]. [从下腹部到腹部:心理测量到临床核心]。

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

N H Grootendorst

引用次数: 0

[Trauma-focused and personality disorder treatment for posttraumatic stress disorder and comorbid cluster C personality disorder]. [创伤集中和人格障碍治疗创伤后应激障碍和共病型C型人格障碍]。

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

A van den End, A T F Beekman, J J M Dekker, K Thomaes

{"title":"[Trauma-focused and personality disorder treatment for posttraumatic stress disorder and comorbid cluster C personality disorder].","authors":"A van den End, A T F Beekman, J J M Dekker, K Thomaes","doi":"","DOIUrl":"","url":null,"abstract":"Background: Posttraumatic stress disorder (PTSD) is associated with high rates of avoidant, dependent and obsessive-compulsive personality disorders (cluster C-PD). It is unknown whether concurrent treatment for PTSD and comorbid cluster C-PD leads to superior treatment effects, compared to standalone trauma-focused treatment.Aim: To test the efficacy of adding 52-58 sessions of PD treatment (group schema therapy; GST) to 12-18 sessions of individual trauma-focused treatment (imagery rescripting; ImRs).Method: 130 adult outpatients were randomized to receive either ImRs or ImRs+GST. The main outcome was PTSD severity one year after start of treatment (CAPS-5). Secondary outcomes were cluster C-PD, psychiatric symptoms, quality of life, functioning, treatment response, remission, and dropout.Results: At 12 months, there were large decreases in PTSD severity (d = 2,4), PD symptoms and all other secondary outcomes. There were no significant differences between conditions.Conclusion: Large effects were observed in both treatment arms. The results suggests that trauma focused treatment is the preferred primary treatment in patients presenting with PTSD and comorbid cluster C-PD, after which more intensive psychotherapy aimed at the personality disorder may be considered in the case of residual personality disorder symptoms.","PeriodicalId":23100,"journal":{"name":"Tijdschrift voor psychiatrie","volume":"67 3","pages":"184-0"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[De behandelrelatie, verplichte zorg én de zoektocht naar perspectief]. [治疗关系、强制护理和寻找视角]。

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

S Berendsen

引用次数: 0

[The organization of psychiatry in the Netherlands and Belgium: who is an example for whom?] [荷兰和比利时的精神病学组织：谁是谁的榜样？]］

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

K R Goethals, T Birkenhäger

{"title":"[The organization of psychiatry in the Netherlands and Belgium: who is an example for whom?]","authors":"K R Goethals, T Birkenhäger","doi":"","DOIUrl":"","url":null,"abstract":"Background: The medical profession such as that of a psychiatrist is a profession with three essential characteristics (specialist care, autonomy and formal recognition, and professional ethics). The 21st century is characterized by bureaucratization and marketization of healthcare. Medical sociologist Friedson described three forms of logic: the logic of the professional, the logic of bureaucracy and the logic of the market.Aim: To test the position, autonomy and effectiveness of the psychiatrist from a historical perspective. To assess developments in Dutch and Belgian psychiatry and make a comparison.Method: Two psychiatrists from Belgium and the Netherlands mention relevant developments. It is examined which form of logic is followed in these developments.Results: The logic of the professional applies to quality and further training, but is threatened by some Boards of Directors and the position of the Dutch psychiatrist. The logic of bureaucracy dominates in the new legislation on compulsory healthcare in the Netherlands. Finally, the powerful health insurers illustrate the logic of the market.Conclusion: The logics of bureaucracy and the market take the upper hand in the Netherlands, to the detriment of the logic of the professional. Extensive bureaucratization and the power of health insurers are not desirable developments for Belgium. Belgians should urgently consider the options for compulsory treatment and mandatory quality and further training.","PeriodicalId":23100,"journal":{"name":"Tijdschrift voor psychiatrie","volume":"67 2","pages":"134-138"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143574033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Psychiatric drug development on the verge of its Rubicon]. [精神科药物的发展处于绝境边缘]。

Tijdschrift voor psychiatrie Pub Date : 2025-01-01

G Jacobs

{"title":"[Psychiatric drug development on the verge of its Rubicon].","authors":"G Jacobs","doi":"","DOIUrl":"","url":null,"abstract":"Background: Recent reports from the psychiatric drug development space have been feeding the expectation of novel pharmacotherapies reaching the clinic over the next couple of years. In this context, advancement of novel compounds such as esketamine, KarXT, MDMA, daridorexant and psilocybine following decades of stagnation, is undoubtedly promising. However, complacency on the side of drug developers and psychiatrist should be considered premature.Method: Discussion of literature, examples and backgrounds of drug development in psychiatry.Results: After all, compared to neurology and oncology, psychiatry is lagging behind in terms of potential new drugs targeting truly novel mechanisms of action to treat psychiatric disorders. The current situation is conceptually related to 1) lacking an understanding of the pathophysiology of psychiatric disorders, 2) limited pharmacological characterization of novel drugs, 3) equating phenomenological diagnostic categories to diseases with a biological basis, and 4) the pharmaceutical industry aiming to introduce ‘blockbuster drugs’ to the market.Conclusion: Altogether, psychiatric drug development is currently undergoing something of a renaissance, but relevant stakeholders seem unable to address the shortcomings and pitfalls of the current approach, risking psychiatric drug development to fall even further behind. Improving drug development in psychiatry is only possible if clinicians, researchers, drug developers and regulators join forces in a concerted effort to address these issues.","PeriodicalId":23100,"journal":{"name":"Tijdschrift voor psychiatrie","volume":"67 2","pages":"105-109"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143574023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0